Articles related to STEM CELLS

Recent studies have highlighted the effectiveness of ruxolitinib in managing steroid-refractory chronic graft-vs-host disease, showcasing a significant improvement in overall response rates and failure-free survival compared to standard therapies.

This recent development regarding survival rates in the study underscores the complexity and challenges in developing effective treatments for ALS.

We invite you to learn more about this groundbreaking stem cell therapy for Parkinson’s disease. This patented method holds great promise and could potentially revolutionize how we treat this debilitating condition.

The FDA’s recent concerns about NurOwn’s efficacy and manufacturing consistency could have far-reaching implications for the future of ALS treatment. Stay updated as the agency’s final decision is expected in December.

The FDA approval of motixafortide in combination with filgrastim offers a new, evidence-based approach to improve stem cell mobilization in multiple myeloma patients undergoing ASCT.

Discover how engineered stem cells could revolutionize the treatment of chronic lung diseases, including pulmonary fibrosis, by offering a more personalized and sustainable approach.